This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Bayerische Julius-Maximilians-Universitat Wurzburg, Julius-Maximilians-Universtitat-Wurzburg. Active years: 2014-2015.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2014-2015
Title: Viacheslav Nikolaev: Innovator in Cyclopeptide Mutants
Introduction
Viacheslav Nikolaev is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel cyclopeptide mutants. With a total of 2 patents, his work has implications for therapeutic and diagnostic applications.
Latest Patents
Nikolaev's latest patents focus on innovative cyclopeptide-mutants that consist of only two cysteine residues capable of forming an intramolecular linkage. These inventions include linear peptides that can form these cyclopeptide mutants and nucleic acid molecules encoding them. Additionally, he has developed vectors and recombinant host cells that incorporate these nucleic acid molecules. His work also encompasses methods for producing these cyclopeptide mutants and compositions that include the peptides, nucleic acid molecules, vectors, or host cells. Furthermore, Nikolaev's inventions relate to therapeutic and diagnostic means, including methods for detecting anti-β-adrenergic receptor antibodies and determining cAMP concentrations both in vitro and in vivo.
Career Highlights
Throughout his career, Nikolaev has been associated with prestigious institutions such as Julius Maximilians University of Würzburg and Bayerische Julius Maximilians Universität Würzburg. His research has significantly advanced the understanding of cyclopeptide mutants and their applications in medicine.
Collaborations
Nikolaev has collaborated with esteemed colleagues, including Martin Lohse and Roland Jahns, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Viacheslav Nikolaev's work in the realm of cyclopeptide mutants showcases his innovative spirit and dedication to advancing biochemistry. His patents and collaborations reflect a commitment to developing new therapeutic and diagnostic tools that could benefit the medical community.